Ledger.Open graph →
SEC Form D · filed September 11, 2018

4D Molecular Therapeutics Inc

Offering
$90.0M
Sold
$90.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
EMERYVILLE, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Tony Yao · Denver, CODirectorTheresa Janke · Emeryville, CAExecMargi Mclaughlin · Emeryville, CADirectorDavid Kirn, M.D · Emeryville, CAExec · DirectorPeter Francis, M.D · Emeryville, CAExecHoyoung Huh, M.D., Ph.D · Emeryville, CADirectorLeisa Johnson, Ph.D · Emeryville, CAExecCharles Theuer, Ph.D · Emeryville, CADirectorDavid Schaffer, Ph.D · Emeryville, CAExec · DirectorTony Yao · Denver, CODirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗